Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Merryn Voysey"'
Autor:
Sue Ann Costa Clemens, Lily Weckx, Ralf Clemens, Ana Verena Almeida Mendes, Alessandra Ramos Souza, Mariana B V Silveira, Suzete Nascimento Farias da Guarda, Maristela Miyamoto de Nobrega, Maria Isabel de Moraes Pinto, Isabela G S Gonzalez, Natalia Salvador, Marilia Miranda Franco, Renata Navis de Avila Mendonça, Isabelle Silva Queiroz Oliveira, Bruno Solano de Freitas Souza, Mayara Fraga, Parvinder Aley, Sagida Bibi, Liberty Cantrell, Wanwisa Dejnirattisai, Xinxue Liu, Juthathip Mongkolsapaya, Piyada Supasa, Gavin R Screaton, Teresa Lambe, Merryn Voysey, Andrew J Pollard, Mustapha Bittaye, Danielle Woods, Sophie Davies, Holly Smith, Marta Ulaszewska, Helen Sanders, Reece Mabette, Sophie Vernon, Zara Valliji, Gracie Mead, Chitra Tejpal, Juyeon Park, Amy Beveridge, Ahmed Eldawi, Sally Felle, Thaiane Muniz Martins, Claudia Loureiro Martins Medrado, Laiana Januse de Arruda Cordeiro Matos
Publikováno v:
Lancet (London, England)
Introduction The inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac, Sinovac) has been widely used in a two-dose schedule. We assessed whether a third dose of the homologous or a different vaccine could boost immune responses. Methods RHH-001 is
Autor:
Shrijana Shrestha, Meeru Gurung, Puja Amatya, Sanjeev Bijukchhe, Anindya Sekhar Bose, Michael J Carter, Madhav C Gautam, Sunaina Gurung, Jason Hinds, Rama Kandasamy, Sarah Kelly, Bibek Khadka, Pratistha Maskey, Yama F Mujadidi, Peter J O’Reilly, Bhishma Pokhrel, Rahul Pradhan, Ganesh P Shah, Sonu Shrestha, Brian Wahl, Katherine L O’Brien, Maria Deloria Knoll, David R Murdoch, Dominic F Kelly, Stephen Thorson, Merryn Voysey, Andrew J Pollard, Kalpana Acharya, Baikuntha Acharya, Imran Ansari, Ruby Basi, Shriya Bista, Sabitri Bista, Arjun Kumar Budha, Saraswati Budhathoki, Rasmila Deshar, Swati Dhungel, Sally Felle, Kushal Gautam, Katie Gorham, Tshering Yanyzon Gurung, Pallavi Gurung, Roshan Jha, Manisha K.C, Shirty Raj Karnikar, Anushiya Kattel, Laxmi Lama, Tham Kumari Pun Magar, Mamata Maharjan, Anshu Mallik, Alexandra Michel, Diksha Nepal, Jita Nepal, Kate M Park, Krishna Govinda Prajapati, Rupa Pudasaini, Subash Shrestha, Matthew Smedley, Rose Weeks, Jyoti Kumari Yadav, Sonu Kumar Yadav
Background In Nepal, Streptococcus pneumoniae (pneumococcus) is a common cause of bacterial pneumonia in children, and is a major health concern. There are few data on the effect of vaccination on the disease or colonisation with pneumococci in the n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c54d22119edd60d527d2f2bdcaa2fb8b
https://doi.org/10.1016/s2214-109x(22)00281-9
https://doi.org/10.1016/s2214-109x(22)00281-9
Autor:
Firdausi Qadri, Karin Sofia Scherrer, Susan Tonks, Kamrul Islam, Melanie Greenland, Sarah Kelly, Mahzabeen Ireen, P J O’Reilly, Golap Babu, Prasanta Kumar Biswas, Katherine Theiss-Nyland, Shams Uddin Ahmed, Ismail Hossen, Nazmul Hasan Rajib, Kathleen M. Neuzil, Andrew J. Pollard, Merryn Voysey, Nicola Smith, John D. Clemens, Arifuzzaman Khan, Virginia E. Pitzer, Yama F Mujadidi, Xinxue Liu, Nazia Rahman, R Colin-Jones, Faisal Ahmmed, Farhana Khanam, O Mazur, Amirul Islam Bhuiyan, K. Zaman
Publikováno v:
The Lancet. 398:675-684
Background Typhoid fever remains a major cause of morbidity and mortality in low-income and middle-income countries. Vi-tetanus toxoid conjugate vaccine (Vi-TT) is recommended by WHO for implementation in high-burden countries, but there is little ev
Autor:
Yuanyuan Liang, Amanda J Driscoll, Priyanka D Patel, Shrimati Datta, Merryn Voysey, Neil French, Leslie P Jamka, Marc Y R Henrion, Latif Ndeketa, Matthew B Laurens, Robert S Heyderman, Melita A Gordon, Kathleen M Neuzil
Publikováno v:
The Lancet. Global health. 11(1)
Typhoid conjugate vaccines are being introduced in low-income and middle-income countries to prevent typhoid illness in children. Vaccine effectiveness studies assess vaccine performance after introduction. The test-negative design is a commonly used
Autor:
Farhana Khanam, Deok Ryun Kim, Xinxue Liu, Merryn Voysey, Virginia E. Pitzer, K. Zaman, Andrew J. Pollard, Firdausi Qadri, John D. Clemens
Publikováno v:
eClinicalMedicine
BACKGROUND: A cluster-randomised trial of Vi-tetanus toxoid (Vi-TT) conjugate vaccine conducted in urban Bangladeshi children found a high level of direct protection by Vi-TT but no significant vaccine herd protection. We reassessed the trial using a
Autor:
Shabir A, Madhi, Vicky, Baillie, Clare L, Cutland, Merryn, Voysey, Anthonet L, Koen, Lee, Fairlie, Sherman D, Padayachee, Keertan, Dheda, Shaun L, Barnabas, Qasim E, Bhorat, Carmen, Briner, Gaurav, Kwatra, Khatija, Ahmed, Parvinder, Aley, Sutika, Bhikha, Jinal N, Bhiman, As'ad E, Bhorat, Jeanine, du Plessis, Aliasgar, Esmail, Marisa, Groenewald, Elizea, Horne, Shi-Hsia, Hwa, Aylin, Jose, Teresa, Lambe, Matt, Laubscher, Mookho, Malahleha, Masebole, Masenya, Mduduzi, Masilela, Shakeel, McKenzie, Kgaogelo, Molapo, Andrew, Moultrie, Suzette, Oelofse, Faeezah, Patel, Sureshnee, Pillay, Sarah, Rhead, Hylton, Rodel, Lindie, Rossouw, Carol, Taoushanis, Houriiyah, Tegally, Asha, Thombrayil, Samuel, van Eck, Constantinos K, Wibmer, Nicholas M, Durham, Elizabeth J, Kelly, Tonya L, Villafana, Sarah, Gilbert, Andrew J, Pollard, Tulio, de Oliveira, Penny L, Moore, Alex, Sigal, Alane, Izu, Peter, Zuidewind
Publikováno v:
The New England Journal of Medicine : NEJM / Publ. by the Massachusetts Medical Society
Background Assessment of the safety and efficacy of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is investigation of the efficacy of the vaccines against emerging SARS-CoV
Autor:
Natalie Gabrielle Marchevsky, Grace Li, Parvinder Aley, Sue Ann Costa Clemens, Jordan Richard Barrett, Sandra Belij-Rammerstorfer, Sagida Bibi, Elizabeth Clutterbuck, Christina Dold, Sally Felle, Amy Flaxman, Pedro Folegatti, Daniel Jenkin, Sarah Gilbert, Sarah Kelly, Teresa Lambe, Emma Plested, Maheshi Ramasamy, Nisha Singh, Holly Smith, Stephen Taylor, Lily Weckx, Andrew John Pollard, Merryn Voysey
Publikováno v:
EBioMedicine. 81
Background There are known differences in vaccine reactogenicity and immunogenicity by sex. Females have been shown to report greater reactogenicity and generate higher humoral and cellular immune responses than males following vaccination with sever
Autor:
Melita A. Gordon, Gordon Dougan, Maile T Phillips, Stephen Baker, Deus Thindwa, Firdausi Qadri, Buddha Basnyat, Thomas C. Darton, John D. Clemens, Merryn Voysey, Kathryn E. Holt, K. Zaman, Farhana Khanam, Susan Tonks, Sabina Dongol, Sarah J. Dunstan, Andrew J. Pollard, Abilasha Karkey, Christiane Dolecek, Mila Shakya, Virginia E. Pitzer, James E Meiring, Robert S Heyderman
Publikováno v:
The Lancet. Global Health
The Lancet Global Health, Vol 9, Iss 12, Pp e1688-e1696 (2021)
The Lancet Global Health, Vol 9, Iss 12, Pp e1688-e1696 (2021)
Background Enteric fever is a serious public health concern in many low-income and middle-income countries. Numerous data gaps exist concerning the epidemiology of Salmonella enterica serotype Typhi (S Typhi) and Salmonella enterica serotype Paratyph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a270ae48236a5e99ddb9a839e60d5dc
https://doi.org/10.1016/s2214-109x(21)00370-3
https://doi.org/10.1016/s2214-109x(21)00370-3
Autor:
Jennifer Hill, Xinxue Liu, A Pradhan, Anup Adhikari, Merryn Voysey, T Lubinda, Kathleen M. Neuzil, Andrew J. Pollard, O Mazur, B Bajracharya, N Haque, Dikshya Pant, Nicola Smith, Stephen Baker, Sarah Kelly, Anju Maharjan, A Dahal, Lisa Stockdale, Yama F Mujadidi, Shrijana Shrestha, Katherine Theiss-Nyland, Buddha Basnyat, R Colin-Jones, Mila Shakya, Gordon Dougan, Susan Tonks, Elizabeth Jones, Abhilasha Karkey, P J O’Reilly, M Joshi, Virginia E. Pitzer, J Clarke, Sabina Dongol
Publikováno v:
The Lancet Global Health, Vol 9, Iss 11, Pp e1561-e1568 (2021)
The Lancet. Global Health
The Lancet. Global Health
Background Typhoid fever is a major public health problem in low-resource settings. Vaccination can help curb the disease and might reduce transmission. We have previously reported an interim analysis of the efficacy of typhoid conjugate vaccine (TCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bea1a1229e076666c9da2b9fd7a1e2fd
https://doi.org/10.1016/s2214-109x(21)00346-6
https://doi.org/10.1016/s2214-109x(21)00346-6
Autor:
Andrew J. Pollard, Sarah Kelly, Celina Jin, R Colin-Jones, Jennifer Hill, Merryn Voysey, Sabina Dongol, Lisa Stockdale, Koeleman Cam., J Clarke, Jan Nouta, E Y Jones, Katherine Theiss-Nyland, Dikshya Pant, Shrijana Shrestha, N. de Haan, Manfred Wuhrer, Buddha Basnyat, M Johnson, Mila Shakya, Abhilasha Karkey, S Marinou
Publikováno v:
Frontiers in Tropical Diseases. 2
Typhoid Vi-conjugate vaccines (Vi-TCV) have been developed to control typhoid fever in children in endemic regions. Previously, in a human challenge model of typhoid, Vi-TCV was administered prior to deliberate ingestion of Salmonella Typhi by health